Balaxi Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue73.2777.2374.5868.9657.77
Expenses67.7171.1664.9168.0756.38
EBITDA6.477.9310.862.372.75
EBIT6.017.4510.401.912.27
Profit Before Tax5.566.079.670.901.38
Net Profit4.595.368.640.290.21
Financial Ratios
Operating Profit Margin8.37%10.82%14.24%3.35%4.89%
Net Profit Margin5.93%7.31%11.33%0.41%0.37%
Earning Per Share (Diluted)0.840.971.560.050.04
Dividends Per Share0.000.000.000.000.00